The AMPD1 C34T mutation is not associated with the status of Israeli athletes

European Journal of Sport Science

Volumn 12, Issue 3, 2012, Pages 244-248

  Meckel, Yoav ^a   Nemet, Dan ^b   Alves, Alberto J ^c   Eliakim, Alon ^b   Eynon, Nir ^a  

^a WINGATE INSTITUTE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

AMPD1; endurance athletes; genetics; sprinters

Indexed keywords

EID: 84859616869     PISSN: 17461391     EISSN: 15367290     Source Type: Journal    
DOI: 10.1080/17461391.2011.552639     Document Type: Article

References (13)

1. Chanock, S. J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D. J.Thomas, G. 2007. Replicating genotype-phenotype associations. Nature, 447: 655-660.
2. Lucia, A., Martin, M. A., Esteve-Lanao, J., San Juan, A. F., Rubio, J. C.Olivan, J. 2006. C34T mutation of the AMPD1 gene in an elite white runner. British Journal of Sports Medicine, 40: e7
3. Maestu, J., Jurimae, J. and Jurimae, T. 2005. Monitoring of performance and training in rowing. Sports Medicine (Auckland, NZ), 35: 597-617.
4. Morisaki, T., Gross, M., Morisaki, H., Pongratz, D., Zollner, N. and Holmes, E. W. 1992. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proceedings of the National Academy of Sciences USA, 89: 6457-6461.
5. Muniesa, C. A., Gonzalez-Freire, M., Santiago, C., Lao, J. I., Buxens, A.Rubio, J. C. 2010. World-class performance in lightweight rowing: Is it genetically influenced? A comparison with cyclists, runners and non-athletes. British Journal of Sports Medicine, 44: 898-901.
6. Norman, B., Glenmark, B. and Jansson, E. 1995. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle and Nerve, 18: 239-241.
7. Norman, B., Sabina, R. L. and Jansson, E. 2001. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. Journal opf Applied Physiology, 91: 258-264.
8. Perez, M., Martin, M. A., Canete, S., Rubio, J. C., Fernandez-Moreira, D.San Juan, A. F. 2006. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?. International Journal of Sports Medicine, 27: 429-435.
9. Rankinen, T., Roth, S. M., Bray, M. S., Loos, R., Perusse, L.Wolfarth, B. 2010. Advances in exercise, fitness, and performance genomics. Medicine and Science in Sports and Exercise, 42: 835-846.
10. Rico-Sanz, J., Rankinen, T., Joanisse, D. R., Leon, A. S., Skinner, J. S.Wilmore, J. H. 2003. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiological Genomics, 14: 161-166.
11. Rubio, J. C., Martin, M. A., Rabadan, M., Gomez-Gallego, F., San Juan, A. F.Alonso, J. M. 2005. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: Does this mutation impair performance?. Journal of Applied Physiology, 98: 2108-2112.
12. Tarnopolsky, M. A., Parise, G., Gibala, M. J., Graham, T. E. and Rush, J. W. 2001. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. Journal of Physiology, 533: 881-889.
13. Tsianos, G. I., Evangelou, E., Boot, A., Zillikens, M. C., van Meurs, J. B.Uitterlinden, A. G. 2010. Associations of polymorphisms of eight muscle-or metabolism-related genes with performance in Mount Olympus marathon runners. Journal of Applied Physiology, 108: 567-574.